Cargando…

CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond

CXCR3 is a chemokine receptor with three ligands; CXCL9, CXCL10, and CXCL11. CXCL11 binds CXCR3 with a higher affinity than the other ligands leading to receptor internalization. Long ago we reported that one of these chemokines, CXCL10, not only attracts CXCR3+ CD4+ and CD8+ effector T cells to sit...

Descripción completa

Detalles Bibliográficos
Autor principal:	Karin, Nathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274023/ https://www.ncbi.nlm.nih.gov/pubmed/32547545 http://dx.doi.org/10.3389/fimmu.2020.00976

Ejemplares similares

Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology
por: Okamoto, Yukari, et al.
Publicado: (2023)

A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15
por: Ocón, Borja, et al.
Publicado: (2017)

γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection
por: Shiromizu, Carolina Maiumi, et al.
Publicado: (2018)

Plasmodium chabaudi AS Infection Induces CD4(+) Th1 Cells and Foxp3(+)T-bet(+) Regulatory T Cells That Express CXCR3 and Migrate to CXCR3 Ligands
por: Berretta, Floriana, et al.
Publicado: (2019)

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
por: Vonderheide, Robert H., et al.
Publicado: (2020)

Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
por: Halova, Ivana, et al.
Publicado: (2012)

Editorial: History of Chemoattractant Research
por: Moser, Bernhard
Publicado: (2015)

Allosteric Modulation of Chemoattractant Receptors
por: Allegretti, Marcello, et al.
Publicado: (2016)

Editorial: The Role of Chemoattractants in the Tumor Microenvironment
por: Bernardini, Giovanni, et al.
Publicado: (2019)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
por: Pan, Zijian, et al.
Publicado: (2022)

Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
por: SenGupta, Shuvasree, et al.
Publicado: (2021)

CXCR3 Identifies Human Naive CD8(+) T Cells with Enhanced Effector Differentiation Potential
por: De Simone, Gabriele, et al.
Publicado: (2019)

Editorial: Atypical Functions of Leukocyte Chemoattractant Receptors
por: Rodríguez-Fernández, José Luis, et al.
Publicado: (2020)

Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
por: Pan, Zijian, et al.
Publicado: (2022)

Immunodeficiency with Autoimmunity: Beyond the Paradox
por: Bacchetta, R., et al.
Publicado: (2013)

Regulatory T Cells Beyond Autoimmunity: From Pregnancy to Cancer and Cardiovascular Disease
por: Martini, Elisa, et al.
Publicado: (2020)

Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity
por: Karin, Nathan
Publicado: (2018)

CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis
por: Hou, Lifei, et al.
Publicado: (2022)

p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity
por: Arena, Andrea, et al.
Publicado: (2021)

The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022)

Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
por: Pawig, Lukas, et al.
Publicado: (2015)

Murine CXCR3(+)CXCR6(+)γδT Cells Reside in the Liver and Provide Protection Against HBV Infection
por: Wang, Yanan, et al.
Publicado: (2022)

Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
por: Wang, Yupeng, et al.
Publicado: (2023)

Neutrophils from Patients with Primary Ciliary Dyskinesia Display Reduced Chemotaxis to CXCR2 Ligands
por: Cockx, Maaike, et al.
Publicado: (2017)

The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases
por: Karin, Nathan, et al.
Publicado: (2015)

Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells
por: Yoshimura, Teizo, et al.
Publicado: (2016)

The role of CXCR3 and its ligands in cancer
por: Wang, Xiaoming, et al.
Publicado: (2022)

Peripheral Autoimmune Regulator Induces Exhaustion of CD4(+) and CD8(+) Effector T Cells to Attenuate Autoimmune Diabetes in Non-Obese Diabetic Mice
por: Kulshrestha, Divakar, et al.
Publicado: (2017)

Commentary: Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
por: Zhang, Jingdan, et al.
Publicado: (2023)

Role of T Cell-To-Dendritic Cell Chemoattraction in T Cell Priming Initiation in the Lymph Node: An Agent-Based Modeling Study
por: Azarov, Ivan, et al.
Publicado: (2019)

Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation—Lessons From Rheumatoid Arthritis
por: Chemin, Karine, et al.
Publicado: (2019)

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
por: Hou, Aihua, et al.
Publicado: (2017)

Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
por: Noels, Heidi, et al.
Publicado: (2016)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Corrigendum: Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells
por: Yoshimura, Teizo, et al.
Publicado: (2017)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
por: Wu, Lan, et al.
Publicado: (2023)

Beyond IgE—When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?
por: Poulsen, Lars K., et al.
Publicado: (2017)

Ras inhibitors gate chemoattractant concentration range for chemotaxis through controlling GPCR-mediated adaptation and cell sensitivity
por: Xu, Xuehua, et al.
Publicado: (2022)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c9n2qut7jmet7g60oqlv15664k